Etravirine: a non-nucleoside reverse transcriptase inhibitor for the treatment of resistant HIV-1 infection.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2008 AND VI 43 AND IP 3
Results: 11
1
2
The pharmacologic management of Crohn's disease.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
3
News capsules. Safety labeling updates & new warnings.
- Published in:
- 2008
- Publication type:
- Journal Article
4
FDA actions in brief.
- Published in:
- Formulary, 2008, v. 43, n. 3, p. 91
- Publication type:
- Article
5
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2008, v. 43, n. 3, p. 115
- Publication type:
- Article
6
Bevacizumab plus paclitaxel can slow breast cancer progression but does not improve overall survival.
- Published in:
- Formulary, 2008, v. 43, n. 3, p. 115
- Publication type:
- Article
7
Etravirine.
- Published in:
- Formulary, 2008, v. 43, n. 3, p. 105
- By:
- Publication type:
- Article
8
The pharmacologic management of Crohn's disease.
- Published in:
- Formulary, 2008, v. 43, n. 3, p. 93
- By:
- Publication type:
- Article
9
Drug Watch.
- Published in:
- Formulary, 2008, v. 43, n. 3, p. 116
- Publication type:
- Article
10
New indication.
- Published in:
- Formulary, 2008, v. 43, n. 3, p. 91
- Publication type:
- Article
11
Pipeline preview.
- Published in:
- Formulary, 2008, v. 43, n. 3, p. 91
- Publication type:
- Article